Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 493

The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.

Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus

Open access
Liou, Jyh-Ming, Malfertheiner, Peter, Lee, Yi-Chia, Sheu, Bor-Shyang, Sugano, Kentaro, Cheng, Hsiu-Chi, Yeoh, Khay-Guan, Hsu, Ping-I, Goh, Khean-Lee, Mahachai, Varocha, Gotoda, Takuji, Chang, Wei-Lun, Chen, Mei-Jyh, Chiang, Tsung-Hsien, Chen, Chieh-Chang, Wu, Chun-Ying, Leow, Alex Hwong-Ruey, Wu, Jeng-Yih, Wu, Deng-Chyang, Hong, Tzu-Chan, Lu, Hong, Yamaoka, Yoshio, Megraud, Francis, Chan, Francis K L, Sung, Joseph JY, Lin, Jaw-Town, Graham, David Y, Wu, Ming-Shiang, El-Omar, Emad M·2020·Gut

Abstract

Objective: A global consensus meeting was held to review current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for prevention of gastric cancer (GC). Methods: 28 experts from 11 countries reviewed the evidence and modified the statements using the Delphi method, with consensus level predefined as ≥80% of agreement on each statement. The Grading of Recommendation Assessment, Development and Evaluation (GRADE) approach was followed. Results: Consensus was reached in 26 statements. At an individual level, eradication of H. pylori reduces the risk of GC in asymptomatic subjects and is recommended unless there are competing considerations. In cohorts of vulnerable subjects (eg, first-degree relatives of patients with GC), a screen-and-treat strategy is also beneficial. H. pylori eradication in patients with early GC after curative endoscopic resection reduces the risk of metachronous cancer and calls for a re-examination on the hypothesis of ‘the point of no return’. At the general population level, the strategy of screen-and-treat for H. pylori infection is most cost-effective in young adults in regions with a high incidence of GC and is recommended preferably before the development of atrophic gastritis and intestinal metaplasia. However, such a strategy may still be effective in people aged over 50, and may be integrated or included into national healthcare priorities, such as colorectal cancer screening programmes, to optimise the resources. Reliable locally effective regimens based on the principles of antibiotic stewardship are recommended. Subjects at higher risk of GC, such as those with advanced gastric atrophy or intestinal metaplasia, should receive surveillance endoscopy after eradication of H. pylori . Conclusion: Evidence supports the proposal that eradication therapy should be offered to all individuals infected with H. pylori . Vulnerable subjects should be tested, and treated if the test is positive. Mass screening and eradication of H. pylori should be considered in populations at higher risk of GC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2020-322368

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 123 references

Cited by

See all 493

Metadata

Authors
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., Gotoda, T., Chang, W.-L., Chen, M.-J., Chiang, T.-H., Chen, C.-C., Wu, C.-Y., Leow, A. H.-R., Wu, J.-Y., Wu, D.-C., Hong, T.-C., Lu, H., Yamaoka, Y., Megraud, F., Chan, F. K. L., Sung, J. J., Lin, J.-T., Graham, D. Y., Wu, M.-S., & El-Omar, E. M.
Venue
Gut
Publisher
BMJ
Published
2020-10-01
Volume
69
Issue
12
Pages
2093-2112
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W3089730087
Cited by
493
References
123
FWCI
47.85
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. https://app.cochat.ai/papers/10.1136/gutjnl-2020-322368
The paper
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., Gotoda, T., Chang, W.-L., Chen, M.-J., Chiang, T.-H., Chen, C.-C., Wu, C.-Y., Leow, A. H.-R., Wu, J.-Y., Wu, D.-C., . . . El-Omar, E. M. (2020). Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. https://doi.org/10.1136/gutjnl-2020-322368

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.